The New York City HIV Care Coordination Program (CCP) combines multiple evidencebased strategies to support persons living with HIV (PLWH) at risk for, or with a recent history of, poor HIV outcomes. We assessed the comparative effectiveness of the CCP by merging programmatic data on CCP clients with population-based surveillance data on all New York City PLWH. A non-CCP comparison group of similar PLWH who met CCP eligibility criteria was identified using surveillance data. The CCP and non-CCP groups were matched on propensity for CCP enrollment within four baseline treatment status groups (newly diagnosed or previously diagnosed and either consistently unsuppressed, inconsistently suppressed or consistently suppressed). We compared CCP to non-CCP proportions with viral load suppression at 12-month follow-up. Among the 13,624 persons included, 15•3% were newly diagnosed; among the 84•7% previously diagnosed, 14•2% were consistently suppressed, 28•9% were inconsistently suppressed, and 41•6% were consistently unsuppressed in the year prior to baseline. At 12-month follow-up, 59•9% of CCP and 53•9% of non-CCP participants had viral load suppression (Relative Risk=1.11, 95%CI:1.08-1.14). Among those newly diagnosed and those consistently unsuppressed at baseline, the relative risk of viral load suppression in the CCP versus non-CCP participants was 1.15 (95%CI:1.09-1.23) and 1.32 (95%CI:1.23-1.42), respectively. CCP exposure shows benefits over no CCP exposure for persons newly diagnosed or consistently unsuppressed, but not for persons suppressed in the year prior to baseline. We recommend more targeted case finding for CCP enrollment and increased attention to viral load suppression maintenance. 4
Introduction
such that their temporal distribution matched that of the enrollment dates among CCP 116 enrollees (i.e., frequency matching). For persons who died, eligibility windows ended at 117 least 12 months prior to the date of death, to ensure 12 months for outcome observation 118 following the pseudo-enrollment date. Step 3. Identify NYC medical care recipients in the non-CCP PLWH group 121 After pseudo-enrollment dates were assigned, we restricted the eligible pool to persons 122 who had at least one valid CD4 or VL test reported to the Registry in the 24 months 123 after the pseudo-enrollment date. We required one laboratory test to identify persons 124 accessing HIV medical care in NYC after the pseudo-enrollment date, as CCP 125 enrollment and service initiation entails connection to NYC HIV medical care (18). ≤200 copies/µL, but not all VLs ≤200 copies/µL, in the 12 months prior to enrollment/pseudo-enrollment).
141
We used logistic regression to estimate the propensity for enrollment in the CCP within 142 each of the above 4 groups. We combined two baseline treatment status groups, 143 groups 3 and 4 for one propensity score model, because we hypothesized the 144 propensity of enrollment in the CCP would be influenced by the same potential 145 confounders for these two groups; when we examined the models separately, the effect 146 estimates from the pooled model did not differ from the effect estimates from the 147 individual models. We report the results for the pooled model because we were able to 148 match more participants. Subsequent matching occurred within each of the four groups. Competing interests 309 The Authors declare that there is no conflict of interest 
